Kanda T - Search Results

1

Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy.

Yasuda I, Hasegawa K, Sakamaki Y, Muraoka H, Kawaguchi T, Kusahana E, Ono T, Kanda T, Tokuyama H, Wakino S, Itoh H. Yasuda I, et al. Among authors: kanda t. J Am Soc Nephrol. 2021 Jun 1;32(6):1355-1370. doi: 10.1681/ASN.2020081188. Epub 2021 Apr 1. J Am Soc Nephrol. 2021. PMID: 33795425 Free PMC article.

2

Impact of calcium antagonists on bleeding time in patients with chronic renal failure.

Hayashi K, Matsuda H, Honda M, Ozawa Y, Tokuyama H, Okubo K, Takamatsu I, Kanda T, Tatematsu S, Homma K, Saruta T. Hayashi K, et al. Among authors: kanda t. J Hum Hypertens. 2002 Mar;16(3):199-203. doi: 10.1038/sj.jhh.1001327. J Hum Hypertens. 2002. PMID: 11896510 Clinical Trial.

3

Altered renal microvascular response in Zucker obese rats.

Hayashi K, Kanda T, Homma K, Tokuyama H, Okubo K, Takamatsu I, Tatematsu S, Kumagai H, Saruta T. Hayashi K, et al. Among authors: kanda t. Metabolism. 2002 Dec;51(12):1553-61. doi: 10.1053/meta.2002.36311. Metabolism. 2002. PMID: 12489067

4

Vessel- and vasoconstrictor-dependent role of rho/rho-kinase in renal microvascular tone.

Nakamura A, Hayashi K, Ozawa Y, Fujiwara K, Okubo K, Kanda T, Wakino S, Saruta T. Nakamura A, et al. Among authors: kanda t. J Vasc Res. 2003 May-Jun;40(3):244-51. doi: 10.1159/000071888. J Vasc Res. 2003. PMID: 12902637

5

Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats.

Kanda T, Wakino S, Hayashi K, Homma K, Ozawa Y, Saruta T. Kanda T, et al. Kidney Int. 2003 Dec;64(6):2009-19. doi: 10.1046/j.1523-1755.2003.00300.x. Kidney Int. 2003. PMID: 14633123 Free article.

6

Cellular mechanism for mibefradil-induced vasodilation of renal microcirculation: studies in the isolated perfused hydronephrotic kidney.

Hayashi K, Ozawa Y, Wakino S, Kanda T, Homma K, Takamatsu I, Tatematsu S, Saruta T. Hayashi K, et al. Among authors: kanda t. J Cardiovasc Pharmacol. 2003 Dec;42(6):697-702. doi: 10.1097/00005344-200312000-00001. J Cardiovasc Pharmacol. 2003. PMID: 14639089

7

Differing anti-proteinuric action of candesartan and losartan in chronic renal disease.

Matsuda H, Hayashi K, Homma K, Yoshioka K, Kanda T, Takamatsu I, Tatematsu S, Wakino S, Saruta T. Matsuda H, et al. Among authors: kanda t. Hypertens Res. 2003 Nov;26(11):875-80. doi: 10.1291/hypres.26.875. Hypertens Res. 2003. PMID: 14714578 Free article. Clinical Trial.

8

Free radical activity depends on underlying vasoconstrictors in renal microcirculation.

Ozawa Y, Hayashi K, Wakino S, Kanda T, Homma K, Takamatsu I, Tatematsu S, Yoshioka K, Saruta T. Ozawa Y, et al. Among authors: kanda t. Clin Exp Hypertens. 2004 Apr;26(3):219-29. doi: 10.1081/ceh-120030231. Clin Exp Hypertens. 2004. PMID: 15132300 Free article.

9

Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease.

Homma K, Hayashi K, Kanda T, Yoshioka K, Takamatsu I, Tatematsu S, Kumagai H, Wakino S, Saruta T. Homma K, et al. Among authors: kanda t. J Hum Hypertens. 2004 Dec;18(12):879-84. doi: 10.1038/sj.jhh.1001761. J Hum Hypertens. 2004. PMID: 15295613 Clinical Trial.

10

Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.

Wakino S, Hayashi K, Kanda T, Tatematsu S, Homma K, Yoshioka K, Takamatsu I, Saruta T. Wakino S, et al. Among authors: kanda t. Circ Res. 2004 Sep 3;95(5):e45-55. doi: 10.1161/01.RES.0000142313.68389.92. Epub 2004 Aug 12. Circ Res. 2004. PMID: 15308580

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,390 results

Search Page

Filters